Investigating how a specific protein affects blood vessel stiffness in hypertension
Endothelial PHD2 in hypertensive vascular remodeling
['FUNDING_R01'] · UNIVERSITY OF MISSISSIPPI MED CTR · NIH-10885988
This study is looking at how a protein called PHD2 affects the stiffness of blood vessels in people with high blood pressure, and it aims to find new ways to help improve blood vessel health and reduce complications from hypertension.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSISSIPPI MED CTR (nih funded) |
| Locations | 1 site (JACKSON, UNITED STATES) |
| Trial ID | NIH-10885988 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of a protein called prolyl hydroxylase-2 (PHD2) in the development of arterial stiffness associated with hypertension. The study examines how changes in PHD2 levels in blood vessel cells can lead to increased recruitment of certain cells that contribute to vascular remodeling and stiffness. By using specialized mouse models, researchers aim to uncover the mechanisms by which PHD2 influences blood vessel health and hypertension. The ultimate goal is to identify new therapeutic targets that could help alleviate the complications of high blood pressure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hypertension, particularly those experiencing arterial stiffness.
Not a fit: Patients with normal blood pressure or those without arterial stiffness may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce arterial stiffness and improve outcomes for patients with hypertension.
How similar studies have performed: Other research has shown promising results in targeting vascular remodeling, suggesting that this approach could lead to significant advancements in hypertension treatment.
Where this research is happening
JACKSON, UNITED STATES
- UNIVERSITY OF MISSISSIPPI MED CTR — JACKSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, JIAN-XIONG — UNIVERSITY OF MISSISSIPPI MED CTR
- Study coordinator: CHEN, JIAN-XIONG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.